Maybe, but insurers can still take back control from climate risk.

The real threat to advisors today is not technology. It is indistinguishability.

Corebridge Financial is counting on steady and strong sales to muscle the company through a period of intense transition.

The proposal “is the most radical shift in ACA regulations since the original ACA regulations were drafted,” one expert said.

Principal Financial Group closed out the fourth quarter with solid performance, driven by steady revenue growth across its main business lines.

Increasing longevity should change the way people prepare for, transition to and live in retirement.

CVS Health President and CEO David Joyner took the brunt of Rep. Alexandria Ocasio-Cortez’s viral broadside on health insurers three weeks ago.

Our industry must adapt to the changing lifestyles and needs of younger consumers

The recent executive order proposing unified federal governance of AI laws has created more uncertainty for insurance companies.

Mitigation is one way to reduce risk exposure.

TrumpRx, a U.S. government–backed prescription drug discount platform, launched Thursday night. How does it work and who will benefit most from it?

Globe Life carved out a niche serving the middle market with smaller policies, a strategy reliant on agent recruitment.

When Congress passed the One Big Beautiful Bill Act (OBBB) in July, it promised stability.

The Cigna Group faced many of the same increased health care cost drivers during the fourth quarter, and it pushed profits down slightly.

Equitable Holdings reported mixed 2025 financial results, posting a full-year loss but returning to profitability in the final quarter.

Pharmacy benefit manager reform, along with other health care measures, was part of legislation signed by President Donald Trump this week, ending a partial government shutdown.

While an expectation of a mass switching frenzy in the year ahead seems logical, the most relevant data says otherwise.

Clients are terrified of doing everything “right” and still running out of money.

With compelling use cases emerging across the life and health sector, the age of artificial intelligence is here.